A Phase 1, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Pharmacokinetics of Single and Multiple Ascending Doses and Effect of Food on the Pharmacokinetics of DM1157 in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2018
At a glance
- Drugs DM-1157 (Primary)
- Indications Malaria
- Focus Adverse reactions; First in man; Pharmacokinetics
- 19 Jul 2018 Status changed from not yet recruiting to recruiting.
- 12 Jul 2018 Planned initiation date changed from 29 Jun 2018 to 2 Aug 2018.
- 07 Jun 2018 Planned initiation date changed from 1 Jun 2018 to 29 Jun 2018.